Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/remegens-telitacicept-rc18-granted-fast-track-designation-by-united-states-fda-for-treatment-of-primary-sjogrens-syndrome-302106576.html
https://www.prnewswire.com/news-releases/remegen-presents-oral-presentation-on-evaluation-of-its-proprietary-disitamab-vedotin-rc48-for-cervical-cancer-at-esgo-2024-302084877.html
https://www.prnewswire.com/news-releases/world-cancer-day-2024-remegen-announces-three-significant-developments-in-the-global-fight-against-cancer-narrowing-the-care-gap-302051872.html
https://www.prnewswire.com/news-releases/remegens-rc88-obtained-fda-fast-track-designation-heralds-new-hope-for-ovarian-cancer-patients-302033529.html
https://www.prnewswire.com/news-releases/remegen-announces-continued-inclusion-of-telitacicept-and-disitamab-vedotin-in-china-national-reimbursement-drug-list-ensuring-continuous-accessibility-of-innovative-drugs-for-more-patients-302017793.html
https://www.prnewswire.com/news-releases/remegen-announces-publication-of-results-from-two-phase-ii-studies-for-disitamab-vedotin-in-latest-issue-of-journal-of-clinical-oncology-jco-301998515.html
https://www.prnewswire.com/news-releases/remegen-to-present-telitacicept-phase-iii-clinical-trial-results-for-rheumatoid-arthritis-patients-in-a-late-breaking-abstract-oral-presentation-session-at-the-american-college-of-rheumatology-301988714.html
https://www.prnewswire.com/news-releases/remegens-telitacicept-shows-significant-promise-in-phase-ii-trial-for-primary-sjogrens-syndrome-findings-published-in-prestigious-rheumatology-journal-301884735.html
https://www.prnewswire.com/news-releases/remegen-and-innovent-collaborate-on-clinical-trials-to-evaluate-the-potential-of-rc88-and-rc108-combined-with-pd-1-therapy-for-advanced-solid-tumors-301872574.html
https://www.prnewswire.com/news-releases/innovent-and-remegen-enter-into-clinical-trial-collaboration-investigating-combination-therapy-of-tyvyt-sintilimab-injection-and-novel-adc-candidates-for-advanced-solid-tumors-in-china-301862538.html